Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01551199 · ClinicalTrials.gov registry record · Phase 1
Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)
A Phase 1 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT01551199: Completed Phase 1 study, sponsored by VA Office of Research and Development.
NCT01551199 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01551199, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid posttraumatic stress disorder (PTSD) and panic disorder (PD) in two phases. The first phase of the study will examine the feasibility and acceptability of MCET-V.
Primary Outcome
The CAPS is a clinician-administered interview assessing 17 symptoms of PTSD (based on DSM-IV criteria). Frequency of symptoms are rated on a scale from 0 (never/none) to 4 (daily/almost every day). Intensity of symptoms are rated using a scale of 0 (none) to 4 (extreme). Total severity score is derived by summing the frequency and intensity scores. A recommended cut-off of 45 is used to determine the presence of full PTSD. Higher scores suggest greater symptom severity.
Interventions
- BEHAVIORAL Multiple Channel Exposure Therapy- Veterans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
What the finished NCT01551199 record still lists
NCT01551199 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Multiple Channel Exposure Therapy- Veterans is the first listed.
NCT01551199 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01551199 about?
NCT01551199 is a clinical study titled "Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)". To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid posttraumatic stress disorder (PTSD) and panic disorder (PD) in two phases. The first phase of the study will examine the fea...
What is the current status of trial NCT01551199?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2012-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01551199?
The interventions under investigation include: Multiple Channel Exposure Therapy- Veterans (BEHAVIORAL).
Who is sponsoring clinical trial NCT01551199?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01551199's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia